These days, fraud is in. The latest example is a biotech executive who forged documents, lied to his lawyers, and pretended to be his own doctor to fake having cancer as a way of wriggling out of a lawsuit. Howard Richman admitted yesterday that he lied to a federal judge about having stage 3 colorectal cancer in order to avoid a trial being brought by the U.S. Securities and Exchange Commission for lying about the development of a synthetic blood substitute. In 2003, he stated publicly that the Cambridge, MA-based Biopure Corporation’s development of Hemopure, a synthetic blood made from cow hemoglobin, was progressing smoothly. Too bad it was a big fat lie: In reality, the clinical trials had failed to get FDA approval. The SEC filed a lawsuit two years later against Biopure, Richman, and three other executives. Each settled the claims, paying between $40,000 and $120,000 in fines, ...
Giving Madoff a Run for His Money: Biotech Exec Fakes Cancer
A biotech executive faked cancer to evade fraud charges, exposing deceit in the industry. Discover the shocking details on biotech executive fraud.
More on Discover
Stay Curious
SubscribeTo The Magazine
Save up to 40% off the cover price when you subscribe to Discover magazine.
Subscribe